Physician profile
Juan Antonio Serrato
NPI 1659551216
$27,337.97
in general payments reported to CMS, 2019-2025
22 companies · $3,719 in 2025
The $3,719 reported for 2025 was more than what 79% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,092 · 2020: $1,140 · 2021: $2,136 · 2022: $4,212 · 2023: $2,198 · 2024: $5,839 · 2025: $3,719.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,791 · Food and Beverage: $4,919 · Education: $46.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,791.23 |
| Food and Beverage | $4,918.55 |
| Education | $46.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $9,808.72 | 2019-2025 | Microraptor, Q-Fix, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Stryker Corporation | $2,566.66 | 2021-2025 | Triathlon, Mako, Gamma |
| Medinc of Texas | $2,036.41 | 2019-2020 | |
| Advanced Orthopaedic Solutions, INC. | $1,978.92 | 2019 | |
| Anika Therapeutics, INC. | $1,880.76 | 2021-2024 | Revomotion |
| Microport Orthopedics INC | $1,786.42 | 2022-2023 | Mpo Medial Pivot Knee |
| Zimmer Biomet Holdings, INC. | $1,616.65 | 2024-2025 | Oxford, Rosa |
| Arthrex, INC. | $1,592.61 | 2019-2020 | |
| Arthrosurface Incorporated | $1,236.90 | 2019 | |
| Depuy Synthes Sales INC. | $822.98 | 2020-2025 | Truespan Orthocord, Orthocord, Healix Knotless Peek |
| Medical Device Business Services, INC. | $759.17 | 2023-2024 | Rigidloop, Attune |
| Linvatec Corporation | $665.41 | 2024 | Biobrace 23mm |
| Radius Health, INC. | $161.13 | 2021-2022 | |
| Horizon Therapeutics Plc | $125.00 | 2023 | Uplizna |
| Pharmacosmos Therapeutics INC. | $116.40 | 2024 | Monoferric |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Motive Health, INC. | $90.00 | 2019 | |
| Catalyst Orthoscience | $83.09 | 2021 | |
| Epimed International, INC | $10.74 | 2022 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juan Serrato listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.